IGF2BP2 and head and neck squamous cell carcinoma: Further analysis of 12 paired HNSCC and ANM tissues confirmed elevated IGF2BP2 mRNA and protein levels in tumors (Figure 3F,G), identifying IGF2BP2 as a key PRMT1 effector.